Beaumont K, Vaughn D A, Fanestil D D
Department of Medicine, University of California, San Diego, La Jolla 92093.
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2311-4. doi: 10.1073/pnas.85.7.2311.
Thiazides and related diuretics inhibit NaCl reabsorption in the distal tubule through an unknown mechanism. We report here that [3H]metolazone, a diuretic with a thiazide-like mechanism of action, labels a site in rat kidney membranes that has characteristics of the thiazide-sensitive ion transporter. [3H]Metolazone bound with high affinity (Kd = 4.27 nM) to a site with a density of 0.717 pmol/mg of protein in kidney membranes. The binding site was localized to the renal cortex, with little or no binding in other kidney regions and 11 other tissues. The affinities of thiazide-type diuretics for this binding site were significantly correlated with their clinical potency. Halide anions (Cl-, Br-, and I-) specifically inhibited high-affinity binding of [3H]metolazone to this site. [3H]Metolazone also bound with lower affinity (Kd = 289 nM) to sites present in kidney as well as in liver, testis, lung, brain, heart, and other tissues. Calcium antagonists and certain smooth muscle relaxants had Ki values of 0.6-10 microM for these low-affinity sites, which were not inhibited by most of the thiazide diuretics tested. Properties of the high-affinity [3H]metolazone binding site are consistent with its identity as the receptor for thiazide-type diuretics.
噻嗪类及相关利尿剂通过未知机制抑制远曲小管中的氯化钠重吸收。我们在此报告,[3H]美托拉宗是一种具有噻嗪样作用机制的利尿剂,它能标记大鼠肾膜中的一个位点,该位点具有噻嗪敏感离子转运体的特征。[3H]美托拉宗以高亲和力(Kd = 4.27 nM)与肾膜中密度为0.717 pmol/mg蛋白质的位点结合。该结合位点定位于肾皮质,在其他肾区和11种其他组织中几乎没有或没有结合。噻嗪类利尿剂对该结合位点的亲和力与其临床效力显著相关。卤化物阴离子(Cl-、Br-和I-)特异性抑制[3H]美托拉宗与该位点的高亲和力结合。[3H]美托拉宗还以较低亲和力(Kd = 289 nM)与肾以及肝、睾丸、肺、脑、心脏和其他组织中的位点结合。钙拮抗剂和某些平滑肌松弛剂对这些低亲和力位点的Ki值为0.6 - 10 microM,大多数测试的噻嗪类利尿剂对其无抑制作用。高亲和力[3H]美托拉宗结合位点的特性与其作为噻嗪类利尿剂受体的身份一致。